SARA EVERMAN: Open Payments
NPI 1851669048 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 132 payments from 14 companies in 2025. Trend: 2023 $2,761 · 2024 $2,283 · 2025 $2,102
Food & beverage: $2,102
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $436 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 29 | $421 |
| Madrigal Pharmaceuticals | 11 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $179 |
| ABBVIE INC. | 11 | $176 |
| Regeneron Healthcare Solutions, Inc. | 11 | $166 |
| Ardelyx, Inc. | 16 | $147 |
| Lilly USA, LLC | 9 | $145 |
| Aimmune Therapeutics, Inc. | 4 | $75 |
| EVOKE PHARMA, INC. | 3 | $55 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, DUPIXENT, IBSRELA, OMVOH, ENTYVIO, CREON.
Industry payments across KY — which companies pay providers there.
